医用大麻用于治疗失眠症
Lucia B Varela1,2, Camila Micaela Escobar Liquitay1, Samanta Díaz Menai1
1Universidad Hospital Italiano de Buenos Aires, Buenos Aires, Argentina.
The Cochrane database of systematic reviews
|April 3, 2025
概括
本审查协议检查了成人失眠的医用大麻. 它旨在评估大麻制品对睡眠质量和患有失眠的成年人相关结果的影响.
科学领域:
- 睡眠医学 睡眠医学
- 药理学 药理学是指药理学的学科.
- 大麻素科学 大麻素科学
背景情况:
- 失眠是一种普遍的睡眠障碍,影响全球数百万人.
- 目前治疗失眠的方法有局限性和副作用.
- 医用大麻越来越多地被用于各种健康状况,包括睡眠障碍.
研究的目的:
- 系统地审查和评估用于治疗成人失眠的医用大麻的疗效和安全性.
- 评估医用大麻对睡眠质量,睡眠时间和其他失眠相关症状的影响.
主要方法:
- 这是柯克伦审查的协议.
- 该审查将综合随机对照试验和观察性研究的证据.
- 将提取和分析数据,以确定医用大麻干预措施的影响.
主要成果:
- 在审查完成后,本部分将报告调查结果.
- 预期结果包括睡眠参数的定量数据和患者报告结果的定性评估.
结论:
- 这次审查将提供基于证据的见解,以医学大麻用于成人失眠.
- 这些发现将为临床实践和未来的睡眠医学和大麻素治疗学研究方向提供信息.
相关概念视频
Management of Insomnia
223
The sleep cycle, an integral part of human health, consists of several stages with distinct characteristics and functions. It begins with a transition from wakefulness to sleep, known as the light sleep phase, followed by the restorative deep sleep phase, essential for physical recovery and growth. The cycle concludes with the Rapid Eye Movement (REM) phase, characterized by high brain activity and vivid dreaming. Insomnia, a prevalent sleep disorder, involves difficulty falling asleep, staying...
223
Insomnia
77
Insomnia is a prevalent sleep disorder characterized by difficulty falling asleep, frequent awakenings during the night, and waking up too early without being able to return to sleep. People with insomnia often experience these disruptions at least three nights a week for at least one month. Chronic insomnia, which lasts for at least three months, can lead to increased anxiety, which in turn can worsen sleep difficulties, creating a cycle of sleeplessness and stress.
Multiple factors contribute...
Multiple factors contribute...
77
Sedatives and Hypnotics Drugs: Miscellaneous Agents
134
Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
134
CNS Depressants: Barbiturates and Benzodiazepines
187
CNS depressants include drugs from the category of barbiturates and benzodiazepines. They are valuable medications for managing anxiety disorders and insomnia. Barbiturates, once used to induce and maintain sleep, have been replaced mainly by benzodiazepines due to barbiturate's toxicity, tolerance, and overdose risks. They interact with GABAA receptors, leading to sedation at low doses and potentially coma and death at higher doses. Phenobarbital, a long-acting barbiturate, possesses...
187
Sedatives and Hypnotics: Overview
241
Sedatives are drugs that alleviate anxiety, while hypnotics induce sleep. Both classes of medication suppress neuronal activity, leading to a calming effect for sedatives and facilitating sleep for hypnotics.
Sedative-hypnotics are categorized into barbiturates, benzodiazepines (BZDs), and non-benzodiazepines or Z-drugs. These drugs work by suppressing central nervous system activity, and this suppression is dose-dependent. Older sedative medications, like barbiturates, follow a linear curve in...
Sedative-hypnotics are categorized into barbiturates, benzodiazepines (BZDs), and non-benzodiazepines or Z-drugs. These drugs work by suppressing central nervous system activity, and this suppression is dose-dependent. Older sedative medications, like barbiturates, follow a linear curve in...
241
Narcolepsy
83
Narcolepsy is a chronic sleep disorder characterized by pervasive, uncontrolled sleepiness and other sleep disturbances. One of its hallmark symptoms is an abrupt transition to REM sleep upon falling asleep, which causes symptoms typically associated with this phase to occur unexpectedly during wakefulness. These include the following symptoms, which typically last from a minute or two to half an hour.
83


